Miller Robert E

No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
12
0 non-derivative · 12 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 14, 2019Expiration(H)5K204K
Jan 14, 2019Expiration(H)68K0
Jan 14, 2019Expiration(H)30K68K
Jan 14, 2019Expiration(H)50K98K
Jan 14, 2019Expiration(H)8K148K
Jan 14, 2019Expiration(H)26K156K
Jan 14, 2019Expiration(H)5K182K
Jan 14, 2019Expiration(H)4K187K
Jan 14, 2019Expiration(H)2K191K
Jan 14, 2019Expiration(H)5K193K
Jan 14, 2019Expiration(H)357198K
Jan 14, 2019Expiration(H)5K198K

Transaction Codes

H
See SEC Form 4 code table

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001683168-19-000117) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about SNOA insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001683168-19-000117"
Ask your agent
Use Arkolith to summarize insider buying and selling at Sonoma Pharmaceuticals, Inc.
over the last 90 days and cite the filings.